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Among a myriad of putative functions assigned to the hepatitis C virus (HCV) core protein, several studies
suggest that it may modulate internal ribosome entry site (IRES)-mediated initiation of translation. We
compared the translational activity of dicistronic reporter transcripts containing the HCV IRES within the
intercistronic space fused to downstream sequence encoding either 22 amino acids (aa) or 173 aa of the core
protein. The inclusion of the nearly full-length core protein-coding sequence significantly suppressed trans-
lation in vitro and in transfected HepG2 cells. However, this suppression was not eliminated by frameshift
mutations introduced into the core sequence, suggesting that it occurred at the RNA level and not as a result
of core protein expression in cis. Similarly, the expression of core protein (aa 1 to 191) in trans from a
recombinant baculovirus did not suppress IRES-directed translation from any of these transcripts in trans-
fected Huh-7 cells. While core protein expression did decrease IRES activity in HepG2 cells (up to 79%
suppression), the expression of b-galactosidase from a control baculovirus also suppressed IRES activity (up
to 56%), strongly suggesting that this suppression was nonspecific. Finally, the addition of purified recombi-
nant core protein (aa 1 to 179) to in vitro translation reactions at concentrations up to a 10-fold molar excess
over the RNA transcripts resulted in no significant reduction in IRES activity. Consistent with these results,
a gel retention assay indicated no difference in the affinities of the recombinant HCV core protein and a
recombinant Venezuelan equine encephalitis virus capsid protein for HCV IRES-containing RNA transcripts.
We conclude that while the inclusion of core protein-coding sequence downstream of the IRES may reduce the
efficiency of cap-independent translation on HCV RNA, the core protein itself has no biologically relevant
activity in modulating HCV IRES activity.
Hepatitis C virus (HCV), the pestiviruses, and GB virus B
(GBV-B) are members of the family Flaviviridae that utilize a
cap-independent mechanism to initiate translation on their
genomic RNAs. This process involves an internal ribosome
entry site (IRES) located in the 59 nontranslated RNA (NTR),
as well as both canonical and noncanonical translation initia-
tion factors (12, 36, 45, 46, 59). The 59 NTRs of these positive-
strand RNA viruses range from 341 nucleotides (nt) in length
in HCV to 445 nt in GBV-B and possess similar RNA second-
ary structures that can be divided into four major structural
domains (Fig. 1). Domains II and III are complex stem-loop
structures, the latter including an RNA pseudoknot, that are
both required for efficient internal ribosome entry (17, 45, 46,
58). Domain IV consists of a stem-loop structure located im-
mediately downstream of the pseudoknot in the genomic
RNAs of HCV and GBV-B. It contains the polyprotein trans-
lation initiation codon within the loop sequence and has been
proposed only for HCV and GBV-B (Fig. 1) (15, 56). A similar
structure does not appear to be present in the genomic RNAs
of the pestiviruses (15, 55), and this structure is not essential
for translation of HCV or GBV-B RNA.
Available evidence suggests that an early step in the internal
initiation of translation on these viral RNAs involves a direct
interaction between the 40S subunit and the viral RNA that is
not dependent upon any canonical translation initiation factors
(35). The 40S subunit interacts with HCV RNA at the site of
the initiator AUG (domain IV) in the absence of any prior
scanning of the ribosome along the RNA (15, 42), and muta-
tions that enhance the predicted stability of the domain IV
stem-loop adversely affect the rate of translation of both HCV
and GBV-B RNAs (15, 44). Thus, it seems likely that the
equilibrium between the folded and unfolded conformations of
stem-loop IV is an important factor in controlling the interac-
tion of the ribosome subunit with the RNA and thus in deter-
mining the efficiency of internal initiation of translation on
HCV and GBV-B RNAs. It has been suggested that the cel-
lular La autoantigen interacts with HCV RNA in the region of
this stem-loop and that this interaction facilitates translation
(1). However, a more attractive hypothesis is that the stem-
loop IV RNA segment might specifically bind a product of viral
translation, thereby down-regulating translation in a manner
that would foster viral persistence (15).
The HCV core protein is the most N-terminal protein of the
viral polyprotein, whose cleavage from the nascent polyprotein
is mediated by host-signal peptidase (8, 13, 60). In addition to
the mature full-length core protein, smaller C-terminally trun-
cated products have been observed in transfected mammalian
cells expressing this protein (49). Core protein is localized to
both the cytoplasm and perinuclear regions of the cell (6, 25,
37). It is an RNA-binding protein, with RNA-binding domains
localized to the N-terminal 75 amino acids (aa), a region rich
in basic amino acids (49). It is a good candidate for a viral
protein that might interact with the IRES. However, while Fan
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et al. (11) reported a specific interaction between the core
protein and the HCV 59 NTR, Santolini et al. (49) found that
the RNA-binding activity of the HCV core protein is not spe-
cific for HCV RNA. Nonetheless, a specific interaction be-
tween the HCV core protein and the 59 NTR was claimed
recently by Shimoike et al. (52), who also suggested that there
is specific suppression of HCV IRES-directed translation in
cells expressing the core protein. If correct, this would add viral
translational regulation to a lengthy list of putative core pro-
tein functions that include, among others, the regulation of
cellular transcription, the modulation of cellular signal trans-
duction pathways, cellular transformation, and immunosup-
pression (7, 21, 23, 30, 34, 38–41, 54, 57, 61), in addition to the
role this protein seems certain to play in viral assembly and
morphogenesis.
These observations have led us to investigate in greater
detail whether the HCV core protein plays a role in IRES-
directed translation. Our results indicate that the inclusion of
the nearly full-length core protein-coding sequence down-
stream of the HCV IRES substantially reduces the efficiency of
IRES-directed translation. However, in contrast to the recent
report from Shimoike et al. (52), we show that the in vivo
expression of core protein, either in cis or in trans, does not
result in a specific inhibition of IRES-directed translation from
dicistronic reporter RNAs. Moreover, we demonstrate that the
core protein of HCV does not differ from the similarly basic
capsid protein of Venezuelan equine encephalitis virus in
terms of its ability either to interact with HCV RNA or to
inhibit HCV IRES-dependent translation in a cell-free trans-
lation system. We conclude from these studies that transla-
tional regulation is not a biologically relevant property of the
HCV core protein.
MATERIALS AND METHODS
Cells. Huh-7 human hepatocellular carcinoma cells were maintained in Dul-
becco’s modified Eagle’s medium. HepG2 cells were maintained in modified
Eagle’s minimum essential medium (Sigma) with L-glutamine, nonessential
amino acids (Gibco-BRL), and sodium bicarbonate at concentrations recom-
mended by the American Type Culture Collection. Sf9 insect cells were main-
tained in spinner flask culture with Grace’s medium (Gibco-BRL) supplemented
with yeastolate, insect hemolymph, and 0.2% Pluronic F-68 solution (Sigma). All
FIG. 1. Proposed model of secondary and tertiary RNA structures within the 59 NTR and the immediate downstream region of HCV-N strain, genotype 1b (18).
The major structural domains are indicated by Roman numerals, while the authentic initiator AUG codon is highlighted at nt 342 in domain IV. The presence of
domains V and VI was suggested by Smith and Simmonds (56).
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media were supplemented with 10% fetal bovine serum, penicillin, and strepto-
mycin (Gibco-BRL).
Plasmids. The dicistronic reporter construct pRC22F was previously referred
to as pRL-HL (16). It contains the Renilla luciferase (RLuc) coding sequence
under the control of a composite T7-cytomegalovirus (CMV) promoter, followed
by the 59 NTR of a genotype 1b HCV (HCV-N) and 66 nt of core protein-coding
sequence fused in-frame directly with the firefly luciferase (FLuc) sequence.
pRC22Ffs is identical to pRC22F except for two frameshift mutations, the
removal of A at nt 357 and the addition of T after nt 402 of the HCV sequence,
both inserted by PCR site-directed mutagenesis. These two frameshift mutations
result in a nonsense protein sequence spanning from aa 5 to the end of the
core-coding sequence. The plasmid pRC173F is similar to pRC22F but contains
core sequence extending to HCV sequence nt 860, fused in-frame with sequence
encoding the foot-and-mouth disease virus (FMDV) 2A proteinase, followed by
FLuc. pRC173Ffs has two frameshift mutations: the removal of A at nt 357 (as
in pRC22Ffs) and the addition of a C after nt 766, inserted by Quick-Change
(Stratagene) site-directed mutagenesis. These mutations place approximately
80% of the core protein sequence out of frame and result in a protein that is
largely nonsense sequence.
Recombinant baculovirus. The recombinant baculoviruses AcCACore,
AcCALacZ, and AcCAG express the HCV core protein (aa 1 to 191) or b-ga-
lactosidase protein under control of the composite mammalian CAG promoter
or contain the CAG promoter only, respectively (53). These were a gift from
Yoshiharu Matsuura of NIH, Japan. Recombinant baculoviruses were amplified
in Sf9 cells using standard protocols (32) and were concentrated as follows.
Seventy-two hours following inoculation, infected Sf9 cultures were collected and
centrifuged at 6,000 3 g for 15 min at 4°C to remove cell debris. Baculovirus
contained in the supernatant was concentrated by ultracentrifugation through a
25% sucrose cushion and was resuspended in phosphate-buffered saline (PBS) at
concentrations near 1010 PFU/ml. The titer of recombinant baculoviruses was
determined by plaque assay on Sf9 cells. Briefly, 8 3 105 Sf9 cells per well were
seeded into six-well plates. Serial dilutions of the concentrated baculovirus stocks
were inoculated onto Sf9 cells in individual wells. The viral inoculum was re-
moved after 1 h, and 2 ml of agarose overlay (0.5% SeaKem agarose and 23
complete Grace’s medium; Gibco-BRL) was added. After the cultures were
incubated for 3 to 5 days at 27°C, the cell monolayers were stained overnight with
neutral red. Plaques were visible as clear areas surrounded by stained cells.
Assessment of HCV translation in vivo. Huh-7 or HepG2 cells grown in
six-well plates were transfected with plasmid DNAs when they were ;70%
confluent. Cells were washed with OptiMEM (Gibco-BRL) twice prior to trans-
fection. Lipofectin-mediated transfection reactions were prepared according to
manufacturer protocols (Gibco-BRL). For each well of a six-well plate, 15 ml of
Lipofectin reagent (Gibco-BRL) was mixed with 1 mg of plasmid DNA in a total
of 200 ml of OptiMEM and was incubated for 15 min at room temperature before
the mixture was added to the cells. OptiMEM (800 ml) was added immediately
after the addition of the Lipofectin-DNA mixture. For experiments involving
protein expression from recombinant viruses, cells were subsequently incubated
at 37°C for 24 h before infection. Huh-7 or HepG2 cells from a test well were
trypsinized, removed, and counted to determine the quantity of baculovirus
required for infection. The baculovirus was then added to the remaining wells at
a multiplicity of infection (MOI) of 100. Following a 1-h virus adsorption period,
1.5 ml of complete medium was added to the cells without removal of the virus
inoculum. Seventy-two hours posttransfection, cells were washed with 13 PBS
and the media were replaced with 0.5 ml of PBS. Cells were then scraped,
collected, and pelleted by centrifugation before being lysed with the passive lysis
buffer provided with the dual luciferase assay (DLA; Promega). The luciferase
reporter activities were determined by DLA and measured in a luminometer. All
experiments were carried out with triplicate samples.
Antibodies and immunofluorescence staining of transfected cells. Murine
monoclonal antibody to the HCV core protein was generously provided by
Johnson Lau of the Schering-Plough Research Institute, Kenilworth, N.J. Fluo-
rescein isothiocyanate-labeled goat anti-mouse antibody (Sigma) was used as the
secondary antibody for immunofluorescence. Cells were grown on glass cover-
slips in six-well plates and were air dried and fixed with 1:1 methanol-acetone
solution. Coverslips were incubated with the murine monoclonal antibody at a
1:350 dilution for 1 h, washed three times with PBS, incubated with the goat
anti-mouse antibody at a dilution of 1:64 for 30 min, washed, and then counter-
stained with DAPI (49,69-diamidino-2-phenylindole) (Molecular Probes) for 5
min to visualize nuclei. The coverslips were inverted onto glass slides with
Vectashield immunofluorescence mounting fluid (Vector Laboratories, Inc.) and
were examined under a Zeiss fluorescence microscope.
In vitro transcription and translation. Dicistronic plasmids were linearized at
the Acc65 I site located immediately downstream of the FLuc sequence. In vitro
transcribed RNAs were synthesized using the T7 MEGAscript in vitro transcrip-
tion kit (Ambion) and were quantitated by agarose gel electrophoresis. RNA
transcripts were used to program the Flexi rabbit reticulocyte lysate system
(Promega) at 12.5 mg/ml per 10 ml of translation reaction. Reactions were
supplemented with HCV core protein (aa 1 to 179) or VEE capsid protein (aa
1 to 275), expressed in Escherichia coli, and purified to near homogeneity under
denaturing conditions. These proteins were generously provided by Stanley
Watowich of the University of Texas Medical Branch (unpublished data). The
translation reactions were carried out at 30°C for 1.5 h, and products were
separated by sodium dodecyl sulfate–12% polyacrylamide gel electrophoresis
(SDS–12% PAGE). Reaction products were quantitated by PhosphorImager
analysis (Molecular Dynamics).
Electrophoretic mobility shift assay. An RNA probe (HCV nt 1 to 770) was
synthesized by runoff transcription using as template the plasmid pMN2-1G (15),
which was linearized by AvrII. Transcription was carried out with [a-32P]CTP
(800 Ci/mmol) using the MEGAscript T7 in vitro transcription kit (Ambion)
reagents. After 2 h of reaction time, the transcription mix was digested with
RNase-free DNase I at 37°C for 15 min. At this point, trichloroacetic acid
precipitation was carried out to assess the specific activity of the probe. Tran-
scripts were then extracted with phenol-chloroform, precipitated with ammo-
nium acetate and isopropanol, and resuspended in nuclease-free water. Binding
reactions were adapted from the conditions described by Schultz et al. (50). Each
reaction (10 ml) contained ;0.5 pmol of radiolabeled probe (2.5 3 105 cpm), 2
mg of yeast tRNA, 1 U of RNasin (Promega), and the appropriate amount of
purified recombinant core protein, VEE capsid protein, or bovine serum albumin
(BSA) for the indicated RNA-to-protein molar ratios. The final binding reac-
tions contained 20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10% (vol/vol) glycerol,
and 0.4 mM dithiothreitol with 25 mM KCl (50). Binding reactions were incu-
bated at room temperature for 10 min before electrophoresis through a non-
denaturing 0.8% agarose gel containing 13 TBE (90 mM Tris borate, 2 mM
EDTA) at 50 V until the bromophenol blue dye front reached the end of the gel.
The gel was dried and subjected to PhosphorImager analysis.
RESULTS
Core protein-coding sequence suppresses HCV IRES-di-
rected translation in vitro. Previous reports have suggested
that the inclusion of a minimal length of core protein-coding
sequence downstream of the IRES is required either for effi-
cient cap-independent translation of reporter proteins (43) or
for the replication of a chimeric poliovirus in which the HCV
IRES replaced the picornavirus translation element (26). In at
least the latter case, it was suggested that this might reflect a
specific transactivating effect of the core protein. On the other
hand, a very recent report suggests that core protein may
specifically suppress translation initiated by the HCV IRES
(52). To assess the influence of core protein expressed in cis
from RNAs that contain the HCV IRES, we used pRC22F and
constructed plasmids pRC22Ffs, pRC173F, and pRC173Fts,
all of which contain dicistronic transcriptional units, as shown
in Fig. 2. Transcripts are produced from each of these plasmids
under the control of a composite CMV-T7 promoter, and they
contain the RLuc sequence as the upstream cistron and the
FLuc sequence as the downstream cistron. The translation of
FLuc from these transcripts is dependent on the HCV IRES
sequence placed in the intercistronic space, while RLuc, trans-
lated from the upstream cistron, serves as an internal control
for transcript abundance. These four plasmids differ with re-
spect to the HCV core protein-coding sequence that is fused
naturally to the 59 NTR, just upstream of the FLuc sequence.
These sequences encode either the amino-terminal 22 aa (66
nt) or 173 aa (519 nt) of the core protein in pRC22F and
pRC173F, respectively, as indicated in Fig. 2. pRC22Ffs and
pRC173Ffs contain similar lengths of the core protein-coding
sequence, but each contains paired frameshift mutations that
result in a significant length of the core protein being trans-
lated as a nonsense sequence out of the wild-type reading
frame. For pRC173F and pRC173Ffs, a 20-aa-long FMDV 2A
autoproteolytic sequence (10) was introduced between the
core and FLuc sequences in order to release the FLuc product
from the lengthier HCV core protein.
To assess the influence of the different downstream HCV
protein-coding sequences on IRES-directed translation, we
programmed in vitro coupled transcription-translation reac-
tions with each of the four plasmids shown in Fig. 2. Figure 3A
shows the SDS-PAGE analysis of the translation products,
which clearly demonstrated the presence of each of the ex-
pected proteins. The pRC22F and pRC22Ffs plasmids resulted
in the expression of both RLuc (36 kDa) and the fusion pro-
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tein, Dcore22-FLuc (;64 kDa). In addition to the expected
RLuc protein, the products from pRC173F and pRC173Ffs
included both the FLuc protein (61 kDa) produced by FMDV
2A-mediated cleavage and the cleavage precursor protein,
Dcore173-FLuc (;83 kDa). The nonsense core products pro-
duced from the frameshift mutants migrated slightly more rap-
idly than the native protein produced from both sets of plas-
mids. Cleavage of the Dcore173-FLuc and Dcore173(fs)-FLuc
products at the FMDV 2A site was approximately 50% effi-
cient. Thus, all four constructs expressed the expected prod-
ucts, indicating that they contain a functional HCV IRES. An
interesting feature of the results shown in Fig. 3A, however,
was the apparent lower abundance of the Dcore173-FLuc and
Dcore173(fs)-FLuc products produced from pRC173F and
pRC173Ffs compared with the Dcore22-FLuc and Dcore22(fs)-
FLuc produced from pRC22F and pRC22Ffs, despite compa-
rable amounts of RLuc produced from each. This indicates
that the presence of the lengthier core-coding sequences in
pRC173F and pRC173Ffs resulted in a significant attenuation
of IRES-directed translation. These differences were not due
to premature termination of transcription in the longer tran-
scripts in these coupled transcription-translation reactions, as
similar results were obtained in cell-free translation reactions
programmed with RNAs prepared in separate in vitro tran-
scription reactions and analyzed by SDS-PAGE (data not
shown).
To better assess the extent to which the inclusion of the
lengthier core-coding sequence affected translation, we quan-
tified the translation products by PhosphorImager analysis
(Fig. 3B). We estimated the relative activities of the IRES
elements in pRC22F and pRC22Ffs by calculating the ratio of
the Dcore22-FLuc to RLuc products produced in reactions
programmed with these plasmids. The IRES activities of
pRC173F and pRC173Ffs were similarly estimated by calcu-
lating the ratio of FLuc plus Dcore173-FLuc (or FLuc alone) to
RLuc. To compare these constructs, the IRES activity of
pRC22F was arbitrarily considered to be 100%, and adjust-
ments were made for the number of Met residues in the trans-
lation products: 14 for pRC22F and pRC22Ffs and 18 for
pRC173F and pRC173Ffs. This analysis indicated that the
activity of the IRES in pRC173F was only 30% that in pRC22F
(taking into account both the cleaved and uncleaved FLuc
products from pRC173F) (Fig. 3B). Thus, the inclusion of the
additional core-coding sequence in pRC173F substantially re-
duced IRES activity. The suppressive effect appeared to be
related primarily to the inclusion of the additional RNA se-
quence and not to the expression of core protein, since there
was little difference between the activity of pRC173F (30%)
and pRC173Ffs (42%), which encodes a nonsense protein that
shares only about 20% sequence identity with core protein
(Fig. 2). Since pRC173F produces a nearly full-length core
protein from the IRES-containing RNA, these results suggest
that the expression of the core protein in cis neither transac-
tivates nor down-regulates HCV IRES activity in this cell-free
translation system.
The results of luciferase assays carried out on the products
of these in vitro translation reactions are shown in Fig. 3C.
Here, IRES activity is presented as the ratio of FLuc to RLuc
activities, relative to that of pRC22F. This analysis confirmed
that the transcripts of pRC22F (100%) and pRC22Ffs (94%)
have comparable IRES activities (Fig. 3C), as shown by the
PhosphorImager analysis (Fig. 3B). The enzymatic assays also
confirmed a substantially lower IRES activity in transcripts
derived from pRC173F (16%) or pRC173Ffs (15%) (Fig. 3C).
However, these last two results were more consistent with the
PhosphorImager quantitation of the cleaved FLuc product
only (19 and 27%, respectively; Fig. 3B) than with the Phos-
phorImager analysis of the total products of translation (30
and 42%, respectively; Fig. 3B). This suggests that the cleavage
precursors, Dcore173-FLuc and Dcore173fs-FLuc, have sub-
stantially reduced luciferase activities.
Expression of core protein in cis does not influence IRES-
directed translation in transfected cells. To determine whether
the core protein-coding sequences included in the dicistronic
constructs shown in Fig. 2 would similarly influence the activity
of the IRES in vivo, we transfected two different human hep-
atocyte-derived cell lines, Huh-7 and HepG2, with these plas-
mids. The cells were harvested 72 h following transfection, and
both reporter protein activities were determined by luciferase
assay. The results in HepG2 cells (Fig. 4A) closely mimicked
those obtained in the cell-free translation system (compare
Fig. 4A and 3C). Compared with the relative luciferase activ-
ities expressed from pRC22F (100%), the translational activi-
ties of the pRC22Ffs, pRC173F, and pRC173Ffs transcripts
FIG. 2. Schematic display of dicistronic reporter plasmids containing the RLuc and FLuc sequences as upstream and downstream reporters flanking various lengths
of HCV sequences containing the 59 NTR. The core sequences are represented as shaded boxes. The frameshifted regions are represented as wavy boxes. Numbers
refer to the nucleotide sequence of HCV.
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FIG. 3. Products of in vitro coupled transcription-translation reactions programmed with the four dicistronic plasmids pRC22F, pRC22Ffs, pRC173F, and
pRC173Ffs. (A) Equal amounts of DNA templates were used to program coupled transcription-translation reactions. Translation products were analyzed in an
SDS–12% PAGE gel. Products are indicated by arrows on the right. (B) The in vitro products were quantitated by PhosphorImager analysis, and the IRES activity of
each construct was determined by calculating the abundance of FLuc relative to RLuc, with that of pRC22F normalized to 100%. Shaded bars indicate IRES activity
determined by measuring the abundance of both cleaved and uncleaved Fluc-containing products relative to RLuc. Hatched bars indicate IRES activity determined
by measuring the abundance of only cleaved FLuc relative to RLuc. Each bar represents the average IRES activity of triplicate translation reactions. (C) IRES activity
estimated from proportional luciferase activity (FLuc/RLuc) of in vitro transcription-translation products, with that of pRC22F normalized to 100%. Each bar
represents the average IRES activity based on RLuc and FLuc activities from triplicate translation samples. (B and C) Error bars indicate the standard deviations of
triplicate samples.
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were 92, 17, and 23%, respectively. Since the comparison of the
quantitative PhosphorImager analysis and enzymatic assays
carried out on in vitro translation products suggested that
uncleaved Dcore173-FLuc fusion proteins have little luciferase
activity (Fig. 3), these enzyme assays of cell lysates are likely to
have overestimated the degree of suppression of IRES activity
caused by the additional core protein-coding sequences in
pRC173F and pRC173Ffs. Nonetheless, they show that the
additional core sequences in pRC173F and pRC173Ffs reduce
IRES activity in HepG2 cells to an extent similar to that ob-
served in vitro. A statistical analysis indicated that these dif-
ferences were highly significant (P , 0.005). As in the in vitro
translation experiments, the suppression of translation ap-
peared to be due to the inclusion of the additional RNA
sequences and not to the expression of a specific protein.
There was no significant difference between the IRES activities
of pRC173F and pRC173Ffs (P . 0.05).
Qualitatively similar results were obtained in transfected
Huh-7 cells (Fig. 4B). However, although the inclusion of ad-
ditional core protein-coding sequence in pRC173F and
pRC173Ffs resulted in a statistically significant reduction in
the ratio of FLuc to RLuc activities produced relative to
pRC22F (P , 0.005), this suppressive effect was quantitatively
less than in the HepG2 cells. The relative luciferase activities
expressed from the pRC173F and pRC173Ffs transcripts were
61 and 64% that of pRC22F, respectively. These differences
may reflect only the reduced specific enzymatic activities of the
uncleaved fusion proteins produced from these constructs.
More importantly, however, there was no difference in the
proportional RLuc and FLuc activities of Huh-7 cells trans-
fected with pRC173F or pRC173Ffs, suggesting again that the
expression of core protein in cis has no effect on translation in
vivo.
Expression of core protein in trans in transfected cells. The
preceding experiments demonstrate that the inclusion of core-
coding sequence significantly reduces the IRES activity of di-
cistronic reporter transcripts, at least in rabbit reticulocyte
lysates and HepG2 cells, and suggest that the core protein does
not have any IRES-modulating activity. To further investigate
this possibility, we transfected the reporter plasmids into
HepG2 and Huh-7 cells. Transfected cells were subsequently
infected with AcCACore, a recombinant baculovirus that ex-
presses the core protein under the transcriptional control of
the composite CAG mammalian promoter. To determine
whether any effects on translation were related specifically to
expression of the core protein, we also transfected the reporter
constructs into cells which were subsequently infected with
AcCAG, a baculovirus containing the CAG promoter only,
and AcCALacZ, a baculovirus that expresses b-galactosidase
under the control of this promoter.
We confirmed the cytoplasmic expression of HCV core from
the recombinant baculovirus AcCACore by immunofluores-
cence staining of Huh-7 and HepG2 cells 48 h after infection at
an MOI of 100 (Fig. 5). Even at this high MOI, the infection of
these cells resulted in no apparent cytopathology, consistent
with the finding of Hofmann et al. (14). Infection with
AcCACore at an MOI of 100 resulted in about 80 to 100% of
HepG2 or Huh-7 cells staining positively for core protein (Fig.
5A and C), similar to the results reported by Shoji et al. (53).
We found that AcCACore infection at an MOI lower than 100
resulted in a lower percentage of core-positive cells, while the
level of core protein in the individual positively stained cells
did not change (data not shown). No antigen was detectable in
cells infected with the control baculovirus, AcCAG (Fig. 5B and
D). In previous studies, core protein expressed from recombi-
nant cDNA was localized to the cytoplasm and perinuclear
regions (6, 22, 24, 25, 31, 48, 51). Although we demonstrated a
similar lack of core within the nuclei of AcCACore-infected
cells (Fig. 5), the cytoplasmic distribution of core in Huh-7 cells
was different from that in HepG2 cells. In the former, core-
specific fluorescence assumed a granular appearance, sugges-
tive of localization of the protein within specific vacuoles or
aggregates, while in the HepG2 cells the staining was diffuse
throughout the cytoplasm (compare Fig. 5C and A). We also
confirmed expression of the core protein by immunoblot anal-
ysis of S-100 fractions prepared from AcCACore-infected
Huh-7 cells, as shown in Fig. 5E. These cells contained an
immunoreactive 22-kDa core protein (Fig. 5E, lane 1) which
was absent in AcCAG-infected Huh-7 cells (Fig. 5E, lane 2).
For comparison, we also included core protein produced in an
FIG. 4. The relative IRES activities of dicistronic reporter transcripts produced in vivo following transfection of HepG2 (A) or Huh-7 (B) cells. Cells were
transfected with equal amounts of the reporter plasmids and assayed for luciferase activity 72 h later. The IRES activity of each construct was determined as described
in Results, with that of the pRC22F set at 100%. Error bars indicate the standard deviations of triplicate samples.
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in vitro translation reaction (Fig. 5E, lane 3). These immuno-
blotting results confirmed the overexpression of a full-length,
22-kDa HCV core protein in AcCACore-infected Huh-7 cells
that did not appear to be processed into smaller proteins as
reported by Santolini et al. (49).
To determine whether the core protein expressed in trans
from the recombinant AcCACore baculovirus is capable of
modulating HCV IRES activity, as suggested recently by Shi-
moike et al. (52), HepG2 or Huh-7 cells were transfected with
the plasmids shown in Fig. 2 and infected with the recombinant
baculoviruses 24 h later. The cells were harvested and assayed
for luciferase activity following incubation for an additional
48 h. In general, infection of either HepG2 or Huh-7 cells with
AcCAG, AcCACore, or AcCALacZ resulted in an increase in
the expression of both the RLuc and FLuc reporter proteins
compared with mock-infected cells (data not shown). This in-
dicates that baculovirus infection of mammalian cells does not
by itself impair cellular translation (consistent with the absence
of a cytopathic effect) but suggests that baculovirus infection
may enhance the efficiency with which transfected liposome-
DNA complexes reach the nucleus and become transcription-
ally active. Of much greater interest was the extent to which
changes in the level of FLuc expression differed from changes
in RLuc expression following infection with these recombinant
baculoviruses, as such differences would be indicative of a
specific effect on IRES-directed translation.
Figure 6 shows the IRES activities, estimated from the pro-
portional RLuc and FLuc content, in HepG2 (Fig. 6A) or
Huh-7 (Fig. 6B) cells transfected with each of the four dicis-
FIG. 5. Core protein-specific immunofluorescence staining of HepG2 cells
infected with AcCACore (A) or AcCAG (B) and of Huh-7 cells infected with
AcCACore (C) or AcCAG (D). DAPI was used for nuclear staining. (E) West-
ern blot analysis of HCV core protein with core-specific monoclonal antibody.
S-100 lysates of Huh-7 cells were separated on an SDS–12% PAGE gel. Lane 1,
lysate from AcCACore-infected Huh-7 cells; lane 2, lysate from AcCAG-infected
Huh-7 cells; lane 3, in vitro translated core protein (aa 1 to 191).
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tronic reporter constructs, with or without overexpression of
the core protein or b-galactosidase. For each of the four di-
cistronic reporter plasmids, the activity of the IRES in mock-
infected cells was arbitrarily set at 100% for this analysis.
Compared with mock-infected HepG2 cells (Fig. 6A, lightly
shaded columns), HCV IRES activities were significantly lower
in cells overexpressing the core protein due to infection with
AcCACore (Fig. 6A, solid columns), irregardless of the re-
porter construct tested. In contrast, infection with the AcCAG
baculovirus, which contains only the CAG promoter and does
not overexpress any protein, had no consistent effect on IRES
activity, resulting in a significant lowering of relative IRES
activity only with the pRC22Ffs reporter construct. Compared
with AcCAG-infected cells, the estimated IRES activity ranged
from 28 to 63% in core-expressing cells infected with AcCACore.
These results are similar to those reported recently by Shi-
moike et al. (52). However, IRES activity was also substantially
reduced in HepG2 cells infected with AcCALacZ, ranging
from 60% (for pRC22Ffs) to 90% (for pRC173F) of the ac-
tivity in AcCAG-infected cells (Fig. 6A). The substantial re-
duction in IRES activity observed with the overexpression of
b-galactosidase from AcCALacZ, while always quantitatively
less than that observed with overexpression of the core protein,
substantially lessens the likelihood that the core-mediated
translational suppression is biologically relevant. In support of
this interpretation, the least degree of core-mediated transla-
tional suppression was observed with the pRC173F reporter
construct, which contains the longest length of native HCV
RNA sequence (Fig. 6A).
The results obtained in baculovirus-infected Huh-7 cells pro-
vided further evidence that the core protein does not modulate
IRES activity. As shown in Fig. 6B, infection with any of the
baculoviruses slightly reduced IRES activity in Huh-7 cells.
However, there were no significant differences between IRES
activities in cells infected with AcCACore versus cells infected
with either of the control baculoviruses, AcCAG and AcCA-
LacZ. This lack of effect of the core protein on translation was
evident with each of the four dicistronic reporter plasmids
tested.
In the experiments shown in Fig. 6, HepG2 or Huh-7 cells
were transfected with the reporter plasmids and then subse-
quently infected with the recombinant baculoviruses. To rule
out the possibility that a minimal effect on IRES activity may
have been missed due to the accumulation of FLuc reporter
protein prior to effective baculovirus overexpression of the
core, we reversed this sequence of events and transfected the
reporter plasmids into cells that had been infected 24 h previ-
ously with baculovirus. As in the experiments shown in Fig. 6,
we observed no specific changes in IRES activity related to
expression of the core protein (data not shown). Thus, in
contrast to the conclusion reached by Shimoike et al. (52), we
conclude that the overexpression of core protein in trans in
human hepatoma cells has no specific effect on HCV transla-
tion.
Recombinant HCV core protein does not influence IRES
activity in vitro. We considered the possibility that core protein
expressed in trans from recombinant baculovirus might be se-
questered in an intracellular compartment where it was not
available for interaction with the RNA transcripts produced
endogenously from the transfected reporter plasmids. To over-
come this potential limitation to the experiments shown in Fig.
6, we determined whether core protein, added directly to an in
FIG. 6. The relative IRES activities of dicistronic reporter transcripts in vivo in cells expressing the core protein from a recombinant baculovirus. HepG2 (A) and
Huh-7 (B) cells were transfected with pRC22F, pRC22Ffs, pRC173F, or pRC173Ffs and then were infected with AcCAG (CAG), AcCACore (Core), or AcCALacZ
(LacZ). mock, no baculovirus infection. The IRES activities of mock-infected cells are normalized to 100%. Error bars represent the standard deviations of triplicate
samples.
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vitro translation reaction, influences the efficiency of transla-
tion directed by the HCV IRES. Purified recombinant HCV
core protein (aa 1 to 179) and VEE capsid protein were ex-
pressed in E. coli (S. Watowich, unpublished data). SDS-
PAGE confirmed that these proteins were of the expected size
and purity (Fig. 7A). The capsid proteins were added to re-
ticulocyte lysates that were programmed for translation with
RNAs transcribed in vitro from the plasmids shown in Fig. 2,
with the amount of protein added calculated to produce an
RNA/protein molar ratio ranging from 100:1 to 1:10. The re-
action products were assayed for luciferase content by DLA to
determine whether the addition of the core or VEE capsid
protein altered IRES activity. The results of this experiment
are shown in Fig. 8, in which the activity of the IRES at the
lowest protein concentration (RNA/protein ratio 5 100:1) is
shown arbitrarily as 100%. The addition of purified core pro-
tein to the translation reactions had no effect on the activity of
the IRES in any of the four dicistronic RNAs. In contrast,
addition of the alphavirus capsid protein resulted in a slight
suppression of IRES activity at the highest protein concentra-
tions (RNA/protein 5 1:10). This was most pronounced with
the pRC22F reporter transcript (Fig. 8A) and was likely due to
nonspecific RNA-protein interactions. The results strongly
suggest that the purified core protein does not have a biolog-
ically relevant effect on IRES activity.
Core protein interaction with HCV RNA. To determine
whether the purified recombinant core protein was capable of
a specific interaction with HCV RNA, we carried out electro-
FIG. 7. (A) SDS-PAGE analysis of purified HCV recombinant core (lane 1)
and VEE capsid (lane 2) proteins. The gel was stained with Coomassie blue. (B)
Electrophoretic mobility shift assays with 32P-labeled HCV RNA (nt 1 to 770).
Lane 1, probe alone; lanes 2 to 4, probe with purified HCV core protein at
RNA/protein molar ratios of 1:1, 1:10, and 1:20, respectively; lanes 5 to 7, probe
with purified VEE capsid protein at RNA/protein ratios of 1:1, 1:10, and 1:100,
respectively; lanes 8 to 10, probe with BSA at RNA/protein ratios of 1:1, 1:10,
and 1:100, respectively.
FIG. 8. Relative IRES activities of dicistronic reporter transcripts pRC22F
(A), pRC22Ffs (B), pRC173F (C), and pRC173Ffs (D) in in vitro translation
reactions supplemented with purified HCV core protein (solid line) or VEE
capsid protein (dashed line) at the indicated RNA to protein molar ratios. RLuc
and FLuc activities of the in vitro products were used to estimate the relative
IRES activities. Each value represents the average IRES activity from triplicate
translation samples. For each dicistronic RNA, the IRES activity of the 100:1
RNA/protein ratio sample was set arbitrarily at 1.00. Error bars indicate the
standard deviations.
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phoretic mobility shift assays using as probe a 32P-labeled HCV
RNA transcript extending from nt 1 to 770. Binding reactions
contained the purified recombinant core protein at the indi-
cated RNA/protein molar ratios, with control reactions con-
taining indicated molar quantities of the recombinant VEE
capsid protein or BSA (Fig. 7B). The recombinant HCV core
protein bound to the RNA probe and retained the probe in the
loading well of the gel when added to the RNA at a 10- (Fig.
7B, lane 3) or 20-fold (lane 4) molar excess. A similar phe-
nomenon was observed with the addition of the VEE capsid
protein at a 10- or 100-fold molar excess (Fig. 7B, lanes 6 and
7), while no retention of the probe was observed with BSA
added at a 100-fold molar excess (Fig. 7B, lane 10). These data
suggest a nonspecific interaction between the viral RNA probe
and the HCV core protein at high protein concentrations that
is shared with the VEE capsid protein. The retention of the
protein-RNA complex in the loading well is consistent with the
homotypic interaction of the core protein and its ability to
form multimers under native conditions (29). Similar observa-
tions have been reported recently by Fan et al. (11).
DISCUSSION
In addition to its role as a structural protein in virus assem-
bly, the HCV core protein has been suggested to have a wide
range of biological activities, each of which could contribute to
the pathogenesis of chronic hepatitis C. These include, among
others, specific interactions with host cell proteins, including
members of the tumor necrosis receptor family, the p53 tumor
suppressor protein, apolipoprotein AII, DBX and other mem-
bers of the DEAD box family of RNA helicases, and hetero-
geneous nuclear ribonuclear protein K (hnTNP K) (3, 19, 22,
27, 28, 33, 47, 62). However, despite an impressive number of
in vitro experiments, evidence supporting the biological rele-
vance of any these putative interactions has been limited by the
absence of HCV-permissive cell cultures or small animal mod-
els of chronic hepatitis C.
Interactions of the core protein with the genomic RNA of
HCV, and the potential effects of the core protein on cap-
independent translation mediated by the HCV IRES, are sim-
ilarly contentious. A possible role for core protein as a trans-
activator of HCV IRES activity was first suggested by studies of
HCV/poliovirus chimeras in which the HCV IRES replaced
the native picornavirus IRES (26). While the inclusion of a
minimal length of core protein-coding sequence appeared to
enhance translation from the chimeric RNA, subsequent work
suggested that the inclusion of a lengthier HCV core sequence
downstream of the IRES improved the replication capacity of
these chimeric viruses by favorably influencing the processing
of the chimeric polyprotein (62). These studies also demon-
strated that the expression of the core protein was not neces-
sary for HCV IRES-directed translation, nor for the replica-
tion of these chimeric viruses. On the other hand, early work by
Reynolds et al. (43) suggested that as much as 33 nt of HCV
core-coding sequence was required downstream of the IRES
for efficient cap-independent translation. However, more re-
cent evidence indicates that this requirement is conditional,
dependent upon the specific reporter sequence, and not abso-
lute (R. Rijnbrand, P. J. Bredenbeek, P. C. Haasnoot, W. J.
Spaan, and S. M. Lemon, submitted for publication). Thus,
there is no clear evidence that the core protein has any positive
trans-activating effect on IRES activity.
More recently, Shimoike et al. (52) have suggested that the
core protein is capable of a specific and profound down-regu-
lation of HCV IRES activity. In large part, the conclusion that
the core protein negatively modulates IRES activity was based
on their finding of significant IRES suppression in HepG2 cells
in which the core protein was expressed from a recombinant
baculovirus, AcCACore, the same as that used by us in the
experiment shown in Fig. 5 and 6. If correct, these data would
be of substantial interest, since the structure of the HCV IRES
and the immediately downstream core-coding sequence (Fig.
1) is very suggestive of the possibility that HCV translation
might be tightly regulated by a viral or cellular protein binding
to stem-loop IV. Minimal increases in the stability of this
structure have been shown to profoundly reduce the efficiency
of cap-independent translation (15). In some prokaryotic sys-
tems, the binding of translation products to RNA structures in
the proximity of the initiation codon has been well documented
as a mechanism of translational repression (2, 5, 9). The direct
interaction of prokaryotic RNAs with the small ribosomal sub-
unit is critically important to this mechanism of translational
regulation and is a feature of prokaryotic translation that is
shared by HCV (35).
Despite the attractive nature of this hypothesis, our data do
not support a role for the core protein in regulating the initi-
ation of translation on HCV RNA. Like Shimoike et al. (52),
we observed significant repression of HCV IRES-directed
translation when we expressed the full-length core protein
from the recombinant baculovirus AcCACore in HepG2 cells
(Fig. 6A). However, we also found substantial reductions in
IRES activity in HepG2 cells expressing b-galactosidase, a
finding that leads us to question the biological relevance of the
repression observed with core protein. Importantly, our exper-
imental approach differed from that of Shimoike et al. (52) in
that we used a dicistronic IRES reporter system (Fig. 2) rather
than monocistronic RNAs. The use of plasmid DNAs that
express dicistronic transcripts in vivo allows a better discrimi-
nation between IRES-directed and cap-dependent translation,
and it is possible that this technical difference contributes to
the variance in the data presented by Shimoike et al. (52) and
those presented here. We also infected cells with these bacu-
loviruses at a higher MOI than Shimoike et al. (52) and may
have achieved expression of the core and b-galactosidase pro-
tein in a greater proportion of cells. Whatever the basis is for
the difference in our findings, the absence of biologically sig-
nificant modulation of IRES-directed translation is strongly
confirmed by the lack of any effect on translation from expres-
sion of either the core protein or b-galactosidase from recom-
binant baculoviruses in Huh-7 cells (Fig. 6B). The lack of even
nonspecific suppression of translation in Huh-7 cells may be
related to the different intracellular distribution of core pro-
tein, which was diffuse and cytoplasmic in HepG2 cells and
discrete and granular in Huh-7 cells (Fig. 5). The basis for this
difference is unknown, but a granular pattern of core expres-
sion has been noted previously in hepatocytes of HCV-infected
chimpanzee (4).
Although it remains to be determined whether the core
protein could specifically modulate viral translation in cell
types other than those we have tested, in vitro evidence sup-
ports the conclusion that there is no biologically relevant re-
pression of HCV translation by the core protein. Specifically,
while we did observe a lower efficiency of translation in reticu-
locyte lysates programmed with dicistronic RNA transcripts
encoding a nearly full-length core protein (pRC173F) than in
transcripts containing only 66 nt of core protein-coding se-
quence (pRC22F), the analysis of related frameshift mutants
indicated that this effect was due to the inclusion of the RNA
sequence in the transcript and not specifically to the expression
of the core protein from these RNAs in cis (Fig. 3). The
suppressive effect of the additional core protein-coding se-
quence is likely to be related to the partial inclusion of a
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polypyrimidine-tract-binding protein binding domain near the
39 end of the HCV sequence in these lengthier RNAs (20), a
long-range RNA-RNA interaction between sequence in the
core protein-coding region and that upstream of the IRES
around nt 34 or 35 (18), and/or the presence of additional
RNA secondary structures shown as stem-loops V and VI in
Fig. 1 (56). Further studies are in progress to distinguish be-
tween these possibilities.
Finally, we observed no significant suppression of IRES-
directed translation when purified recombinant core protein
(aa 1 to 179) was added to reticulocyte lysates at a 10-fold
molar excess over the HCV RNA used to program the trans-
lation reaction (Fig. 8). With each of the four dicistronic HCV
transcripts tested, greater (but still only slight) repression of
HCV translation was observed with the addition of recombi-
nant VEE capsid protein. These results are consistent with the
results of RNA gel retention experiments depicted in Fig. 7B,
which show an interaction of both of these proteins with the
viral RNA at high molar excess of the protein and which are
consistent with the nonspecific RNA-binding activity of core
protein described by Santolini et al. (49).
On the basis of these results, we are forced to conclude that
the HCV core protein plays no specific role in regulating the
translational activity of the viral IRES. The likelihood that this
is so is strengthened by the probability that the molar concen-
tration of the core protein in each of the experimental systems
we used to assess this hypothesis is likely to significantly exceed
that of the core protein present within the hepatocytes of
persons with chronic hepatitis C. The discordance in the con-
clusions reached by Shimoike et al. (52) and those arrived at
here attests to the difficulties inherent in working with a viral
pathogen that cannot be propagated efficiently in any cell cul-
ture system and for which no small animal model is available.
It also highlights the care that must be taken in claiming the
biological relevance of intermolecular interactions observed in
isolated in vitro or cell-based systems.
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